- Home
- PEB vs JANX Comparison
PEB vs JANX Comparison
Compare PEB & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEB
- JANX
- Stock Information
- Founded
- PEB 2009
- JANX 2017
- Country
- PEB United States
- JANX United States
- Employees
- PEB N/A
- JANX N/A
- Industry
- PEB Real Estate Investment Trusts
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- PEB Real Estate
- JANX Health Care
- Exchange
- PEB Nasdaq
- JANX Nasdaq
- Market Cap
- PEB 1.2B
- JANX 1.4B
- IPO Year
- PEB 2009
- JANX 2021
- Fundamental
- Price
- PEB $10.50
- JANX $25.86
- Analyst Decision
- PEB Hold
- JANX Strong Buy
- Analyst Count
- PEB 8
- JANX 11
- Target Price
- PEB $12.29
- JANX $76.55
- AVG Volume (30 Days)
- PEB 3.3M
- JANX 833.4K
- Earning Date
- PEB 11-05-2025
- JANX 11-05-2025
- Dividend Yield
- PEB 0.37%
- JANX N/A
- EPS Growth
- PEB N/A
- JANX N/A
- EPS
- PEB N/A
- JANX N/A
- Revenue
- PEB $1,469,933,000.00
- JANX $439,000.00
- Revenue This Year
- PEB $2.11
- JANX N/A
- Revenue Next Year
- PEB $2.83
- JANX $91.66
- P/E Ratio
- PEB N/A
- JANX N/A
- Revenue Growth
- PEB 2.00
- JANX N/A
- 52 Week Low
- PEB $7.42
- JANX $21.73
- 52 Week High
- PEB $15.12
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- PEB 35.55
- JANX 60.91
- Support Level
- PEB $11.33
- JANX $22.23
- Resistance Level
- PEB $10.98
- JANX $24.57
- Average True Range (ATR)
- PEB 0.33
- JANX 1.36
- MACD
- PEB -0.16
- JANX 0.20
- Stochastic Oscillator
- PEB 4.03
- JANX 95.60
About PEB Pebblebrook Hotel Trust of Beneficial Interest
Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,933 rooms across 46 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.